Please use this identifier to cite or link to this item:
https://doi.org/10.21256/zhaw-19725
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Hengartner, Michael Pascal | - |
dc.contributor.author | Jakobsen, Janus C. | - |
dc.contributor.author | Sørensen, Anders | - |
dc.contributor.author | Plöderl, Martin | - |
dc.date.accessioned | 2020-03-12T13:51:54Z | - |
dc.date.available | 2020-03-12T13:51:54Z | - |
dc.date.issued | 2020 | - |
dc.identifier.issn | 1932-6203 | de_CH |
dc.identifier.uri | https://digitalcollection.zhaw.ch/handle/11475/19725 | - |
dc.description.abstract | It has been claimed that efficacy estimates based on the Hamilton Depression Rating-Scale (HDRS) underestimate antidepressants true treatment effects due to the instrument's poor psychometric properties. The aim of this study is to compare efficacy estimates based on the HDRS with the gold standard procedure, the Montgomery-Asberg Depression Rating-Scale (MADRS). | de_CH |
dc.language.iso | en | de_CH |
dc.publisher | Public Library of Science | de_CH |
dc.relation.ispartof | PLOS ONE | de_CH |
dc.rights | https://creativecommons.org/licenses/by/4.0/ | de_CH |
dc.subject.ddc | 616.8: Neurologie und Krankheiten des Nervensystems | de_CH |
dc.title | Efficacy of new-generation antidepressants assessed with the Montgomery-Asberg depression rating scale, the gold standard clinician rating scale : a meta-analysis of randomised placebo-controlled trials | de_CH |
dc.type | Beitrag in wissenschaftlicher Zeitschrift | de_CH |
dcterms.type | Text | de_CH |
zhaw.departement | Angewandte Psychologie | de_CH |
zhaw.organisationalunit | Psychologisches Institut (PI) | de_CH |
dc.identifier.doi | 10.1371/journal.pone.0229381 | de_CH |
dc.identifier.doi | 10.21256/zhaw-19725 | - |
dc.identifier.pmid | 32101579 | de_CH |
zhaw.funding.eu | No | de_CH |
zhaw.issue | 2 | de_CH |
zhaw.originated.zhaw | Yes | de_CH |
zhaw.pages.start | e0229381 | de_CH |
zhaw.publication.status | publishedVersion | de_CH |
zhaw.volume | 15 | de_CH |
zhaw.publication.review | Peer review (Publikation) | de_CH |
zhaw.webfeed | Klinische Psychologie | de_CH |
zhaw.author.additional | No | de_CH |
Appears in collections: | Publikationen Angewandte Psychologie |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
2020_Hengartner-etal_New-generation-antidepressants.pdf | 898.34 kB | Adobe PDF | View/Open |
Show simple item record
Hengartner, M. P., Jakobsen, J. C., Sørensen, A., & Plöderl, M. (2020). Efficacy of new-generation antidepressants assessed with the Montgomery-Asberg depression rating scale, the gold standard clinician rating scale : a meta-analysis of randomised placebo-controlled trials. Plos One, 15(2), e0229381. https://doi.org/10.1371/journal.pone.0229381
Hengartner, M.P. et al. (2020) ‘Efficacy of new-generation antidepressants assessed with the Montgomery-Asberg depression rating scale, the gold standard clinician rating scale : a meta-analysis of randomised placebo-controlled trials’, PLOS ONE, 15(2), p. e0229381. Available at: https://doi.org/10.1371/journal.pone.0229381.
M. P. Hengartner, J. C. Jakobsen, A. Sørensen, and M. Plöderl, “Efficacy of new-generation antidepressants assessed with the Montgomery-Asberg depression rating scale, the gold standard clinician rating scale : a meta-analysis of randomised placebo-controlled trials,” PLOS ONE, vol. 15, no. 2, p. e0229381, 2020, doi: 10.1371/journal.pone.0229381.
HENGARTNER, Michael Pascal, Janus C. JAKOBSEN, Anders SØRENSEN und Martin PLÖDERL, 2020. Efficacy of new-generation antidepressants assessed with the Montgomery-Asberg depression rating scale, the gold standard clinician rating scale : a meta-analysis of randomised placebo-controlled trials. PLOS ONE. 2020. Bd. 15, Nr. 2, S. e0229381. DOI 10.1371/journal.pone.0229381
Hengartner, Michael Pascal, Janus C. Jakobsen, Anders Sørensen, and Martin Plöderl. 2020. “Efficacy of New-Generation Antidepressants Assessed with the Montgomery-Asberg Depression Rating Scale, the Gold Standard Clinician Rating Scale : A Meta-Analysis of Randomised Placebo-Controlled Trials.” Plos One 15 (2): e0229381. https://doi.org/10.1371/journal.pone.0229381.
Hengartner, Michael Pascal, et al. “Efficacy of New-Generation Antidepressants Assessed with the Montgomery-Asberg Depression Rating Scale, the Gold Standard Clinician Rating Scale : A Meta-Analysis of Randomised Placebo-Controlled Trials.” Plos One, vol. 15, no. 2, 2020, p. e0229381, https://doi.org/10.1371/journal.pone.0229381.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.